| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/06/2009 | WO2009096579A1 Nutritional composition for prevention of hyperglycemia |
| 08/06/2009 | WO2009096503A1 Benzyl phenyl glucopyranoside derivative |
| 08/06/2009 | WO2009095377A1 Spiro compounds as npy y5 receptor antagonists |
| 08/06/2009 | WO2009095265A1 The use of substances for the treatment of central or peripheral insulin receptor impairment and insulin resistance |
| 08/06/2009 | WO2009094866A1 Dicycloazaalkane derivates, preparation processes and medical uses thereof |
| 08/06/2009 | WO2009094846A1 Insulin nasal powder inhalation |
| 08/06/2009 | WO2009043522A3 Use of a peptide as a therapeutic agent |
| 08/06/2009 | WO2009043463A3 Use of gluten exorphin c : as a therapeutic agent |
| 08/06/2009 | WO2009036149A3 Methods for treatment of degenerative disease associated with apoptosis |
| 08/06/2009 | WO2009033795A3 Use of a obestatin as a therapeutic agent |
| 08/06/2009 | WO2009033794A3 Use of endothelin-1, optionally in combination with obestatin, as a therapeutic agent |
| 08/06/2009 | WO2009033793A3 Pentagastrin as a therapeutic agent |
| 08/06/2009 | WO2009033721A3 Use of salusin beta alone or in combination with octreotide as a therapeutic agent |
| 08/06/2009 | US20090197965 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 08/06/2009 | US20090197951 Substituted Fullerene Formulations and Their Use in Ameliorating Oxidative Stress Diseases or Inhibiting Cell Death |
| 08/06/2009 | US20090197945 Method for Generating Reference Controls for Pharmacogenomic Testing |
| 08/06/2009 | US20090197926 Benzimidazoles and their use for the treatment of diabetes |
| 08/06/2009 | US20090197894 Nicotinamide derivatives and their use as therapeutic agents |
| 08/06/2009 | US20090197890 Pyridazine derivatives and their use as therapeutic agents |
| 08/06/2009 | US20090197869 Azepine inhibitors of janus kinases |
| 08/06/2009 | US20090197857 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 08/06/2009 | US20090197831 Composition for the Treatment of Obesity and Hyperlipidemia |
| 08/06/2009 | US20090197830 Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia |
| 08/06/2009 | US20090197806 Adiponectin for treatment of various disorders |
| 08/06/2009 | US20090197805 Insulin receptor antagonists and related compositions, uses and methods |
| 08/06/2009 | US20090197802 Analogues of GLP-1 |
| 08/06/2009 | US20090197800 Insulin Receptor Binding Peptides with Non-Insulin Gene Activation Profiles and Uses Thereof |
| 08/06/2009 | US20090197795 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 08/06/2009 | US20090197337 Methods for the production of multimeric proteins and related compositions |
| 08/06/2009 | US20090196940 Compositions and methods for supporting heat shock function |
| 08/06/2009 | US20090196912 Pyridinylamines |
| 08/06/2009 | US20090196878 Intestinal epithelial glucose sensor |
| 08/06/2009 | US20090196876 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/06/2009 | US20090196848 Absorbent ingestible agents and associated methods of manufacture and use |
| 08/06/2009 | CA2854933A1 Methods and compositions using soluble klotho proteins |
| 08/06/2009 | CA2712352A1 Dicycloazaalkane derivates, preparation processes and medical uses thereof |
| 08/05/2009 | EP2085406A1 Long lasting insulin derivatives and methods thereof |
| 08/05/2009 | EP2085391A2 Inhibitors of factor XA and other serine proteases involved in the coagulation cascade |
| 08/05/2009 | EP2085389A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085388A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085387A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085091A1 Use of hydrochloric acid in manufacture of medicament for treating disease caused by fouling of transport tract |
| 08/05/2009 | EP2085089A1 Phospholipids Containing omega-3-Fatty Acids for the Treatment of Overweight, Obesity and Addictive Behavior |
| 08/05/2009 | EP2085086A2 Method for treating congestive heart failure or diabetic nephropathy |
| 08/05/2009 | EP2084541A2 Diagnostic and therapeutic uses of peptides for pre-forms of type 2 diabetes and conditions associated therewith |
| 08/05/2009 | EP2084149A1 Organic compounds |
| 08/05/2009 | EP2084140A1 Arginine derivatives with np-i antagonistic activity |
| 08/05/2009 | EP2084127A1 Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
| 08/05/2009 | EP2083836A1 Nutritional supplement |
| 08/05/2009 | EP2083831A2 Method of treatment using fatty acid synthesis inhibitors |
| 08/05/2009 | EP2083817A2 Method of restoring the incretin effect |
| 08/05/2009 | EP2083813A2 Nutrient sensor |
| 08/05/2009 | EP2083622A1 Omega-3 fatty acids for reduction of lp-pla2 levels |
| 08/05/2009 | EP1924560B1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 08/05/2009 | EP1919474B1 Pyrrolopyridine derivatives and use of same as ppar receptor modulators |
| 08/05/2009 | EP1771178B1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 08/05/2009 | EP1753721B1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems |
| 08/05/2009 | EP1744774A4 Nutritional composition which promotes weight loss, burns calories, increases thermogenesis, supports energy metabolism and/or suppresses appetite |
| 08/05/2009 | EP1713803B1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments |
| 08/05/2009 | EP1680106B1 Combination treatment of obesity involving 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity and lipase inhibitors |
| 08/05/2009 | EP1635799B1 Pharmaceutical formulations of amyloid inhibiting compounds |
| 08/05/2009 | EP1509506B1 Pyridazine derivatives |
| 08/05/2009 | EP1503778B1 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| 08/05/2009 | EP1496052B1 Novel aminobenzamide derivative |
| 08/05/2009 | EP1465880B1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine |
| 08/05/2009 | EP1461313B1 Human adam-10 inhibitors |
| 08/05/2009 | EP1430040B1 Benzothiazepine derivatives |
| 08/05/2009 | EP1407004B1 Ex-vivo priming for generating cd40-ligand specific cytotoxic t lymphocytes to treat autoimmune and allergic disease |
| 08/05/2009 | EP1399445B1 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 08/05/2009 | EP1296974B1 2-cyanopyrrolidine derivatives and their use as medicaments |
| 08/05/2009 | EP1286703B1 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 08/05/2009 | EP1282432B1 Use of peptide antagonists of zonulin for prevention or delay of the onset of diabetes |
| 08/05/2009 | EP1249233B9 Npyy5 antagonists |
| 08/05/2009 | CN101501049A Aminophosphoric acid ester derivative and S1P receptor modulator containing the same as active ingredient |
| 08/05/2009 | CN101501038A Fused [d]pyridazin-7-ones |
| 08/05/2009 | CN101501026A Protein kinase C activity enhancer containing alkyl ether derivative or salt thereof |
| 08/05/2009 | CN101501007A Quinazoline derivative |
| 08/05/2009 | CN101500611A Combination of a cholinesterase inhibitor and a compound with 5-HT6 receptor affinity |
| 08/05/2009 | CN101500610A Anti-obesity agent and use thereof |
| 08/05/2009 | CN101500563A Cycloalkanopyrolocarbazole derivatives and the use thereof as PARP, VEGFR2 and MLK3 inhibitors |
| 08/05/2009 | CN101500560A Tetrahydro pyridinyl pyrazole cannabinoid modulators |
| 08/05/2009 | CN101497906A Separation and purification preparation as well as hypoglycemic activity of tea polysaccharide |
| 08/05/2009 | CN101497851A Healthcare wine |
| 08/05/2009 | CN101497654A Melanocortin receptor agonists |
| 08/05/2009 | CN101497641A Method for synthesizing delta 24(28) cholesterol compounds |
| 08/05/2009 | CN101496879A Medicament for treating diabetes and preparation method thereof |
| 08/05/2009 | CN101496872A Chinese medicinal composition for reducing blood fat and preparation method thereof |
| 08/05/2009 | CN101496864A Chinese medicament preparation for treating renal proteinuria and diabetic renal proteinuria and preparation method thereof |
| 08/05/2009 | CN101496857A Blood-activating, stasis-resolving, qi-regulating and analgesic dropping pill and preparation method thereof |
| 08/05/2009 | CN101496843A Haw thorn leaf total flavone effervescent tablet and method for producing the same |
| 08/05/2009 | CN101496829A Medicament composition for treating diabetes and preparation method thereof |
| 08/05/2009 | CN101496818A Kidney-nourishing and bone-tonifying chewable tablet and preparation method thereof |
| 08/05/2009 | CN101496806A Use of compound extracted from bitter melon in preparing medicament for preventing and treating diabetes and fat disease |
| 08/05/2009 | CN101496790A Acarbose chewable tablet |
| 08/05/2009 | CN101496621A Seaweed sausage suitable for diabetic and preparation method thereof |
| 08/05/2009 | CN101496604A Nutrient foodstuffs with function for reducing blood fat and preparation method thereof |
| 08/05/2009 | CN101496583A Nutrient foodstuffs containing probiotic and preparation method thereof |
| 08/05/2009 | CN101496581A Health-care food for adjusting blood fat |
| 08/05/2009 | CN101496580A Special diet and foodstuffs formula containing small peptide for diabetic |
| 08/05/2009 | CN100523198C Method for detection of leptin receptor ligands |